INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE EVIDENCE INDEX

The Study Library.

8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.

Pooled results from many studies on one question.

160 studies · page 2 of 7

2023 / Systematic review of clinical trials

Bariatric surgery exhibited higher weight reduction and diabetes management efficacy than semaglutide, but carried a higher risk of complications.

A systematic review compared the efficacy and safety of semaglutide with bariatric surgery using data from trials including STEP, SUSTAIN, PIONEER, STAMPEDE, and the LABS consortium. Semaglutide demonstrated significant weight reduction, though adverse events included gastrointestinal disturbances, increased pulse rate, rare thyroid cancer cases, and partial weight regain after withdrawal. Bariatric surgery showed higher efficacy in weight reduction and diabetes management targets compared to medical therapy alone, but also carried a higher risk of complications.

Klair N, Patel U, Saxena A, et al. Cureus, 2023. PMID 37905277

2023 / Systematic review and meta-analysis

A 10% increase in ultra-processed food consumption was linked to higher risks of diabetes, cardiovascular diseases, obesity, and cancer.

A systematic review and meta-analysis of 18 research articles evaluated the dose-response relationship between ultra-processed food (UPF) consumption and noncommunicable diseases. UPF consumption significantly increased daily intake of carbohydrates (49.64%), added sugar (40.78%), saturated fat (30.00%), sodium (27.76%), energy (26.67%), cholesterol (25.69%), and total fat (15.77%), while fiber intake was -38.55% below recommendations. Each 10% increase in UPF intake was significantly linked to higher risks of diabetes (HR ± 95% CI: 1.115 ± 0.044), cardiovascular diseases (1.096 ± 0.053), obesity (1.068 ± 0.050), and cancer (1.020 ± 0.020).

Shows an association, not proof of cause and effect.

Bestari FF, Andarwulan N, Palupi E Foods, 2023. PMID 38137261

2022 / Systematic review of interventional trials

Plant-predominant diets generally improved weight control and cardiometabolic outcomes compared with usual and some health-oriented diets.

A systematic review of 84 interventional trials (RCTs and non-randomized trials lasting at least 4 weeks) evaluated the efficacy of plant-predominant diets for treating obesity and cardiometabolic sequelae. In general, plant-based diets demonstrated improved weight control, lipids, cardiovascular end points, blood pressure, insulin sensitivity, A1C, fasting glucose, and a lower risk of diabetes compared with usual diets and in some cases standard health-oriented diets. Preliminary studies suggested that plant-predominant diets within healthy lifestyle interventions may stabilize or even reverse type 2 diabetes and cardiovascular disease. Acceptability and sustainability were generally similar to other health-oriented diets.

Remde A, DeTurk SN, Almardini A, et al. Nutr Rev, 2022. PMID 34498070

2022 / Systematic review and meta-analysis

Arthrospira (Spirulina) supplementation significantly reduced fasting blood sugar, total cholesterol, and triglycerides, while increasing HDL-C in clinical studies.

A systematic review and meta-analysis of 7 clinical and 27 preclinical studies evaluated the effect of Arthrospira (Spirulina) on glycemic and lipid markers. In clinical studies, Arthrospira significantly reduced fasting blood sugar (MD -1.77, 95% CI -2.90 to -0.63), total cholesterol (MD -2.54, 95% CI -4.61 to -0.46), and triglycerides (MD -3.71, 95% CI -6.54 to -0.89), while increasing HDL-C (MD 2.27, 95% CI 0.67 to 3.86). However, it did not significantly reduce HbA1c (MD -0.59, 95% CI -2.23 to 1.04) or LDL-C in humans. Subgroup analyses showed significant FBS reductions with doses under 2 grams [-3.22 (-5.67, -0.76)] and durations under 2 months [-2.52 (-4.37, -0.67)].

Ghanbari F, Amerizadeh A, Behshood P, et al. Curr Probl Cardiol, 2022. PMID 34538515

2022 / Systematic review and meta-analysis of RCTs

Synbiotic supplementation significantly improved several cardiometabolic and anthropometric indices in patients with metabolic syndrome.

A systematic review and meta-analysis evaluated five randomized controlled trials including 1049 participants with metabolic syndrome to assess the effects of synbiotic interventions. Synbiotic supplementation significantly reduced serum insulin (WMD -6.39 μU/mL), triglycerides (WMD -20.3 mg/dl), total cholesterol (WMD -7.8 mg/dl), LDL cholesterol (WMD -9.02 mg/dl), waist circumference (WMD -4.04 cm), body weight (WMD -4.3 kg), systolic blood pressure (WMD -1.8 mmHg), and IL-6 (WMD -0.2 pg/mL), while increasing HDL cholesterol (WMD 2.3 mg/dl). No significant effects were observed for fasting plasma glucose, HOMA-IR, BMI, diastolic blood pressure, heart rate, or C-reactive protein.

Arabi SM, Bahrami LS, Rahnama I, et al. Pharmacol Res, 2022. PMID 34999222

2022 / Systematic review and meta-analysis of prospective cohorts

Higher intake of heme iron is linked to increased type 2 diabetes risk.

A systematic review and meta-analysis of 11 prospective cohort studies with 323,788 participants and 28,837 incident cases evaluated dietary iron and type 2 diabetes risk. Higher heme iron consumption was associated with a 20% greater risk of diabetes (RR 1.20, 95% CI 1.07 to 1.35), with each 1 mg/day increment linked to a 16% risk increase (RR 1.16, 95% CI 1.03 to 1.30). Total, non-heme, and supplemental iron showed no significant associations.

Shows an association, not proof of cause and effect.

Shahinfar H, Jayedi A, Shab-Bidar S Eur J Nutr, 2022. PMID 35107626

2022 / Meta-analysis of clinical studies

NAD+ precursor supplementation improved lipid profiles but raised blood glucose levels in humans.

A meta-analysis of 40 articles (14,750 cases) evaluated the effects of NAD+ precursors (NR, NMN, NA, and NAM) on lipid and glucose metabolism. NAD+ precursor supplementation significantly reduced TG (SMD = -0.35, P < 0.0001), TC (SMD = -0.33, P = 0.0005), and LDL (SMD = -0.38, P < 0.00001), while increasing HDL (SMD = 0.66, P < 0.00001) and plasma glucose (SMD = 0.27, P = 0.0004). Subgroup analyses indicated nicotinic acid (NA) had the most significant effects on these markers, with significant benefits seen in patients with cardiovascular disease and dyslipidemia but little effect in healthy people. The authors note the conclusions are limited by the number and quality of included studies.

Zhong O, Wang J, Tan Y, et al. Nutr Metab (Lond), 2022. PMID 35303905

2022 / Systematic review and meta-analysis of randomized clinical trials

GLP-1 receptor agonist use was linked to increased risks of gallbladder and biliary diseases in a meta-analysis of randomized clinical trials.

A systematic review and meta-analysis of 76 RCTs with 103,371 patients examined the risk of gallbladder or biliary diseases associated with GLP-1 receptor agonists compared to placebo or non-GLP-1 RA drugs. Randomization to GLP-1 RA treatment was associated with increased risk of gallbladder or biliary diseases (RR 1.37; 95% CI, 1.23-1.52), including cholelithiasis (RR 1.27; 95% CI, 1.10-1.47), cholecystitis (RR 1.36; 95% CI, 1.14-1.62), and biliary disease (RR 1.55; 95% CI, 1.08-2.22). Risks were higher in trials for weight loss (RR 2.29; 95% CI, 1.64-3.18) than for type 2 diabetes or other diseases (RR 1.27; 95% CI, 1.14-1.43), as well as with higher doses (RR 1.56 vs 0.99 for lower doses) and longer durations of use (RR 1.40 vs 0.79 for shorter duration).

He L, Wang J, Ping F, et al. JAMA Intern Med, 2022. PMID 35344001

2022 / Systematic review and meta-analysis of randomized controlled trials

Taurine supplementation significantly reduced HbA1c, fasting blood sugar, and HOMA-IR in patients with diabetes.

A meta-analysis of 5 randomized controlled trials (N = 209 participants) evaluated the effects of taurine supplementation in patients with diabetes. Compared with controls, taurine significantly reduced HbA1c (SMD -0.41 [95% CI: -0.74, -0.09], p = 0.01), fasting blood sugar (SMD -1.28 [95% CI: -2.42, -0.14], p = 0.03), and HOMA-IR (SMD -0.64 [95% CI: -1.22, -0.06], p = 0.03). Reductions in insulin (SMD -0.48 [95% CI: -0.99, 0.03], p = 0.06) and triglycerides (SMD -0.26 [95% CI: -0.55, 0.02], p = 0.07) did not reach statistical significance, and no significant effects were found for serum lipids, blood pressure, or body composition.

Tao X, Zhang Z, Yang Z, et al. Food Chem (Oxf), 2022. PMID 35769396

2022 / Systematic review and meta-analysis of RCTs

Isolated soluble dietary fibre supplementation for at least 12 weeks significantly reduced body weight in overweight and obese individuals.

A systematic review and meta-analysis of randomised controlled trials evaluated isolated soluble dietary fibre supplementation for at least 12 weeks in overweight and obese patients. Compared with controls, participants receiving fibre supplementation showed a significantly higher reduction in body weight (MD -1.25 kg, 95% CI -2.24, -0.25; 27 RCTs; 1428 participants). Fibre supplementation was also accompanied by significant decreases in BMI, waist circumference, fasting blood insulin, and HOMA-IR.

Huwiler VV, Schönenberger KA, Segesser von Brunegg A, et al. Nutrients, 2022. PMID 35807808

2022 / Umbrella review of systematic reviews and meta-analyses

Nut intake of 28 g/day was linked to lower risks of cardiovascular disease, cancer deaths, and all-cause mortality in an umbrella review.

An umbrella review analyzed 89 articles on nut and seed consumption and health outcomes, including 23 meta-analyses on disease and mortality and 66 on biomarkers. Eating 28 g/d of nuts compared with not eating nuts was associated with a 21% relative risk reduction in cardiovascular disease, an 11% reduction in cancer deaths, and a 22% reduction in all-cause mortality. Nut intake was also inversely associated with mortality from respiratory diseases, infectious diseases, and diabetes, though associations with diabetes incidence were mixed. Allergy and adverse reactions were reported in 1-2% of adult populations with substantial heterogeneity.

Shows an association, not proof of cause and effect.

Balakrishna R, Bjørnerud T, Bemanian M, et al. Adv Nutr, 2022. PMID 36041171

2021 / Umbrella review of systematic reviews and meta-analyses

Milk consumption was associated with lower risk of multiple conditions including CVD and obesity, but higher risk of prostate cancer and Parkinson's disease.

An umbrella review examined 41 meta-analyses with 45 unique health outcomes in humans to evaluate the evidence on milk intake. Dose-response analyses indicated that a 200 ml per day increment in milk intake was linked to a lower risk of cardiovascular disease, stroke, hypertension, colorectal cancer, metabolic syndrome, obesity, and osteoporosis, with beneficial associations also observed for type 2 diabetes mellitus and Alzheimer's disease. Conversely, milk intake was associated with a higher risk of prostate cancer, Parkinson's disease, acne, and iron-deficiency anemia in infancy, with caution noted for potential allergy or lactose intolerance.

Shows an association, not proof of cause and effect.

Zhang X, Chen X, Xu Y, et al. Nutr Metab (Lond), 2021. PMID 33413488

2021 / Systematic review and meta-analysis of randomized clinical trials

Low-carbohydrate diets increased type 2 diabetes remission rates at six months, but benefits largely diminished by 12 months.

A systematic review and meta-analysis evaluated 23 randomized trials (1,357 participants) testing low (<130 g/day or <26% energy) and very low (<10% energy) carbohydrate diets (LCDs and VLCDs) for at least 12 weeks in adults with type 2 diabetes. At six months, LCDs achieved higher rates of diabetes remission defined as HbA1c <6.5% compared to control diets (57% vs 31%; risk difference 0.32, 95% CI 0.17 to 0.47), though effect sizes were smaller and non-significant when remission was defined as HbA1c <6.5% without medication. Clinically important improvements in weight loss, triglycerides, and insulin sensitivity at six months diminished by 12 months, and data on 12-month remission were sparse. At 12 months, participants experienced clinically important but not statistically significant worsening of quality of life and LDL cholesterol.

Goldenberg JZ, Day A, Brinkworth GD, et al. BMJ, 2021. PMID 33441384

2021 / Dose-response meta-analysis of prospective studies

Caffeinated coffee consumption was inversely associated with risk of CVD, type 2 diabetes, endometrial cancer, melanoma, and nonmelanoma skin cancer.

A dose-response meta-analysis of prospective studies evaluated caffeinated coffee intake and select health outcomes. In any coffee consumers, there was a significant inverse association with the risk of CVD (RR = 0.90; 95% CI: 0.84, 0.96), T2D (RR = 0.90; 95% CI: 0.85, 0.96), endometrial cancer (RR = 0.85; 95% CI: 0.78, 0.92), melanoma (RR = 0.89; 95% CI: 0.80, 0.99), and nonmelanoma skin cancer (RR = 0.92; 95% CI: 0.89, 0.95). Consumption was also inversely associated with HCC without reaching statistical significance (RR = 0.93; 95% CI: 0.80, 1.08). The dose-response relation was nonlinear uniquely for CVD (P-nonlinearity = 0.01), with the largest risk reduction observed for 3-4 cups/d and no reduction thereafter, whereas risk decreased linearly for other outcomes.

Shows an association, not proof of cause and effect.

Di Maso M, Boffetta P, Negri E, et al. Adv Nutr, 2021. PMID 33570108

2021 / Systematic review

Limited evidence supports high-dose micronutrient supplements for COVID-19, but preventing obesity and type 2 diabetes reduces serious outcome risks.

A systematic review synthesized data on 13 nutrition-related components and COVID-19 across 22 published articles, 38 preprint articles, and 79 trials identified up to August 2020. The authors found limited evidence that high-dose micronutrient supplements prevent severe disease or hasten recovery, with clinical trial results awaited. However, strong evidence indicates that the prevention of obesity and type 2 diabetes will reduce the risk of serious COVID-19 outcomes.

James PT, Ali Z, Armitage AE, et al. J Nutr, 2021. PMID 33982105

2021 / Systematic review and database compilation

Updated 2021 international tables compile over 4,000 food entries, showing consistent low GIs for dairy, legumes, pasta, and fruits, with wide variation in cereals.

Researchers systematically reviewed and tabulated published and unpublished sources of GI values, expanding the database to over 4000 items (a 61% increase from 2008). Data were divided into approximately 2100 items measured via ISO-recommended methods and approximately 1900 items from less robust methods. Dairy products, legumes, pasta, and fruits were generally low-GI (≤55 on the glucose scale), whereas cereals, breads, rice, and savory snacks varied widely across low, medium, and high GI. Most potato varieties were high GI, though specific low-GI varieties were identified.

Atkinson FS, Brand-Miller JC, Foster-Powell K, et al. Am J Clin Nutr, 2021. PMID 34258626

2021 / Umbrella review of meta-analyses of randomized controlled trials

Current evidence does not support resveratrol supplementation for managing cardiometabolic risk factors in patients with type 2 diabetes, MetS, or NAFLD.

An umbrella review analyzed meta-analyses of randomized controlled trials examining resveratrol supplementation compared to control groups in patients with type 2 diabetes, metabolic syndrome, and NAFLD. While resveratrol showed beneficial effects on some markers (such as blood pressure, lipids, glycemic control, and waist circumference), the magnitude of effect was generally trivial, evidence certainty was very low to low, or trials were too few. Resveratrol showed a clinically important short-term (<12 weeks) reduction in HbA1c (mean difference: -1.05%, 95% CI: -2.09% to -0.02%; n = 6; moderate certainty), though evidence overall does not support supplementation for cardiometabolic management.

Zeraattalab-Motlagh S, Jayedi A, Shab-Bidar S Am J Clin Nutr, 2021. PMID 34320173

2021 / Systematic review and meta-analysis

Obesity, smoking, older age, male sex, and various comorbidities were linked to increased risk of COVID-19 mortality in hospitalized patients.

A systematic review and meta-analysis of 42 studies with 423,117 patients assessed clinical risk factors associated with COVID-19 mortality. The pooled prevalence of mortality among hospitalized patients was 17.62% (95% CI 14.26-21.57%). Increased mortality risk was linked to older age (pOR 2.61, pHR 1.31), male sex (pOR 1.45, pHR 1.24), and current smoking status (pOR 1.42). Obesity, acute kidney injury, chronic obstructive pulmonary disease, cardiovascular disease, diabetes, hypertension, cancer, and increased D-dimer were also reported as clinical risk factors for fatal outcomes.

Shows an association, not proof of cause and effect.

Dessie ZG, Zewotir T BMC Infect Dis, 2021. PMID 34418980

2021 / Systematic review and meta-analysis of randomized controlled trials

Resveratrol supplementation significantly lowered HOMA-IR in type 2 diabetes patients, without significant effects on total cholesterol or triglycerides.

A systematic review and meta-analysis evaluated 15 RCTs involving 896 patients with type 2 diabetes to assess the efficacy and safety of resveratrol supplements. Compared with controls, HOMA-IR was significantly lower in the resveratrol group (WMD: -0.99; 95% CI -1.61, -0.38; P=0.002). No statistically significant differences were observed for total cholesterol (WMD: -7.11; 95% CI -16.28, 2.06; P=0.13), triglycerides (WMD: -2.15; 95% CI -5.52, 1.22; P=0.21), or adverse events (WMD: 2; 95% CI 0.44, 9.03; P=0.37).

Zhang T, He Q, Liu Y, et al. Evid Based Complement Alternat Med, 2021. PMID 34484395

2021 / Systematic review

Plant-based and vegan diets were linked to improved gut microbiota symbiosis, increased insulin sensitivity, and weight control mechanisms.

Following PRISMA guidelines, researchers conducted a systematic review using databases including PubMed, Web of Science, Scopus, and Embase. Results showed that vegan diets are associated with improved gut microbiota symbiosis, increased insulin sensitivity, activation of peroxisome proliferator-activated receptors, and over-expression of mitochondrial uncoupling proteins. Key features reported were reduced calorie density and reduced cholesterol intake, suggesting plant-based and vegan diets might play a significant role in weight reduction strategies.

Shows an association, not proof of cause and effect.

Ivanova S, Delattre C, Karcheva-Bahchevanska D, et al. Foods, 2021. PMID 34945602

2020 / Umbrella review of systematic reviews and meta-analyses

Magnesium shows strong evidence for pregnancy hospitalization and migraine, with observational diabetes links.

An umbrella review synthesized 16 meta-analyses encompassing 55 outcomes from randomized trials and observational cohorts. High-grade evidence from trials indicated magnesium supplementation decreased pregnancy-related hospitalizations and migraine attack frequency and intensity. In observational studies, baseline magnesium consumption was associated with lower incidence of type 2 diabetes (highly suggestive evidence) and stroke (suggestive evidence).

Veronese N, Demurtas J, Pesolillo G, et al. Eur J Nutr, 2020. PMID 30684032

2020 / Meta-analysis of interventional studies

Vinegar consumption improved fasting glucose and HbA1c in adults with type 2 diabetes.

A meta-analysis evaluated six interventional studies involving 317 patients with type 2 diabetes mellitus to assess glycemic control. Vinegar consumption significantly improved fasting blood glucose and hemoglobin A1c levels. Secondary outcomes revealed reductions in total cholesterol and low-density lipoprotein. The authors noted that sample sizes were relatively small and vinegar formulations varied.

Cheng LJ, Jiang Y, Wu VX, et al. J Adv Nurs, 2020. PMID 31667860

2020 / Meta-analysis of observational studies

Higher ferritin levels were linked to an increased risk of gestational diabetes mellitus.

A meta-analysis of 10 observational studies involving 4,690 participants was conducted to evaluate the relationship between ferritin levels and gestational diabetes mellitus (GDM). Comparing the highest with the lowest ferritin categories, the summary relative risk for GDM was 1.87 (95% CI 1.50-2.34; I2 = 20.1%). A linear dose-response analysis of four studies showed that each 10 μg/L increase in ferritin was associated with an 8% higher risk of GDM (RR 1.08, 95% CI 1.05-1.13, I2 = 55.1%), with non-linear analysis also showing consistently increasing risk. The authors noted that further prospective cohort studies are needed to confirm the results, especially regarding the dose-response relationship.

Shows an association, not proof of cause and effect.

Sun C, Wu QJ, Gao SY, et al. J Diabetes Investig, 2020. PMID 31667982

2020 / Systematic review and dose-response meta-analysis of RCTs

Psyllium consumption significantly reduced triglycerides, LDL cholesterol, fasting blood sugar, and HbA1c in patients with diabetes.

A systematic review and meta-analysis of eight randomized controlled trials evaluated the effects of psyllium in 395 diabetic participants. Psyllium consumption led to significant reductions in triglycerides (WMD: -19.18 mg/dl, 95% CI [-31.76, -6.60]), low-density lipoprotein (WMD: -8.96 mg/dl, 95% CI [-13.39, -4.52]), fasting blood sugar (WMD: -31.71 ml/dl, 95% CI [-50.04, -13.38]), and hemoglobin A1c (WMD: -0.91%, 95% CI [-1.31, -0.51]). There were no significant changes in high-density lipoprotein, body mass index, cholesterol, or weight.

Xiao Z, Chen H, Zhang Y, et al. Phytother Res, 2020. PMID 31919936